imipenem, anhydrous has been researched along with Blood Poisoning in 142 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (15.49) | 18.7374 |
| 1990's | 33 (23.24) | 18.2507 |
| 2000's | 41 (28.87) | 29.6817 |
| 2010's | 32 (22.54) | 24.3611 |
| 2020's | 14 (9.86) | 2.80 |
| Authors | Studies |
|---|---|
| Cirioni, O; Di Matteo, F; Ghiselli, R; Giacometti, A; Kamysz, W; Lukasiak, J; Mocchegiani, F; Orlando, F; Riva, A; Saba, V; Scalise, G; Silvestri, C | 1 |
| Eb, F; Guillon, H; Mammeri, H | 1 |
| Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Pulse, ME; Weiss, WJ | 1 |
| Becker, P; Chausse, J; Gous, A; Milne, M; Mitton, B; Paruk, F; Said, M | 1 |
| Bozali, K; Cakir, A; Celikten, M; Durdu, B; Guler, EM; Kocyigit, A; Sahan, E; Sumbul, B | 1 |
| Chen, W; Huang, C; Ji, J; Shi, Q; Wu, H; Wu, S; Xiao, Y; Ying, C | 1 |
| Jia, L; Jiang, Y; Li, X; Peng, Z; Wang, Y | 1 |
| Leng, T; Li, XL; Liao, QF; Shu, L; Wu, CY; Xiao, YL; Xie, Y; Zhang, WL | 1 |
| Hashemi, SM; Hosseini, AZ; Khaligh, SG; Khosrojerdi, A; Soudi, S | 1 |
| Johnson, MR; Lambden, S; Leiper, J; Nasri, NM; Zölner, J | 1 |
| AlAzmi, A; AlHashem, G; Jamal, W; Khodakhast, FB; Rotimi, VO; Sόki, J | 1 |
| Guo, F; Huang, Y; Liu, L; Liu, S; Qiu, H; Xie, J; Yang, J; Yang, Y | 1 |
| Huang, Y; Li, Q; Liu, L; Liu, S; Shao, H; Xie, J; Xu, K; Yang, Y; Zha, X; Zhan, Y | 1 |
| Ghaffari Khaligh, S; Hashemi, SM; Khosrojerdi, A; Soudi, S; Zavaran Hosseini, A | 1 |
| Bu, Y; Guo, N; Han, C; Jia, X; Li, X; Liu, X; Ma, X; Peng, Y; Wang, C; Yang, M; Yu, K; Zhang, J | 1 |
| Hackel, MA; Lob, SH; Motyl, MR; Sahm, DF; Young, K | 1 |
| Gandi, DS; Hua, Y; Shi, Q; Xu, Y; Yang, X; Yao, J; Zhang, Y; Zhu, Y | 1 |
| Bickler, SW; Cauvi, DM; Coimbra, R; De Maio, A; Escobedo, O; Halbach, JL; Hawisher, D; Lizardo, RE; Reyes, T; Rosas, J; Wang, AW | 1 |
| Chen, Z; Hu, X; Li, F; Li, Z; Liang, Y; Ma, Z; Tang, H; Wu, J; Yang, W; Zeng, L | 1 |
| Dong, J; Guo, P; Tang, S; Wu, F; Wu, J; Yang, J; Zhang, J; Zhang, S; Zhang, W | 1 |
| Abdellatif, S; Abdennebi, C; Ben Lakhal, S; Daly, F; Nasri, R; Touil, Y; Trifi, A | 1 |
| Gong, S; Hu, X; Jiang, Y; Li, J; Shang, X; Yu, R; Zhang, X; Zhang, Y | 1 |
| Docobo-Pérez, F; Domínguez-Herrera, J; Egea, P; López-Cerero, L; López-Rojas, R; Pachón, J; Pascual, A; Rodríguez-Baño, J | 1 |
| Chen, DC; Guan, J; Li, WF; Lin, ZF; Liu, SZ; Liu, XF | 1 |
| Imon, K; Ishino, T; Kayama, S; Kuwahara, R; Ohge, H; Onodera, M; Shigemoto, N; Sugai, M; Yokozaki, M | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F; Metan, G | 1 |
| Chen, JC; Chen, JY; Lin, TL; Pan, CY; Sheen, JF | 1 |
| Bellevue, O; Brown, I; Harris, HW; Kasravi, S; Lee, M; Lyo, V; Rayikanti, B; Shawo, A; Uzosike, ED; Woldesemayat, H | 1 |
| Araya, I; Contreras, S; Fasce, G; Hurtado, V; Núñez, E; Opazo, JL; Quiñones, LA; Saez, E | 1 |
| Choudhury, S; Darzi, SA; Dash, JR; Debroy, B; Kannan, K; Mishra, SK; Parida, S; Paul, A; Pule Addison, M; Singh, TU; Singh, V; Thangamalai, R | 1 |
| Colp, P; Holbein, BE; Islam, S; Jarosch, S; Lehmann, C; Parquet, Mdel C; Toguri, JT; Zhou, J | 1 |
| Madi, DR; Ramapuram, J; Shetty, AK; Vidyalakshmi, K | 1 |
| Addison, MP; Choudhury, S; Darzi, SA; Dash, JR; Kandasamy, K; Kasa, JK; Maruti, BS; Mishra, SK; Parida, S; Singh, TU; Singh, V | 1 |
| Ayerbe Algaba, R; Díaz, C; Gutiérrez Valencia, A; Jiménez Mejías, ME; López Cortés, LF; Pachón Ibáñez, ME; Pachón, J; Parra Millán, R; Pérez Del Palacio, J; Sánchez Encinales, V; Smani, Y | 1 |
| Deng, LY; Gong, YL; Huang, GT; Jiang, B; Peng, YZ; Yang, ZC; Yin, SP | 1 |
| Saito, H; Starr, ME; Steele, AM | 1 |
| Aranda, F; Armiger-Borràs, N; Carrasco, E; Consuegra-Fernández, M; Di Scala, M; González-Aseguinolaza, G; Lozano, F; Martínez-Florensa, M; Pachón, J; Vila, J | 1 |
| Flores, M; Murillo, J; Stumpf, PG | 1 |
| Chen, XG; Jiang, WL; Tian, JW; Zhu, HB | 1 |
| Chen, XG; Fu, FH; Jiang, WL; Qu, GW; Tian, JW; Yue, XD; Zhu, HB | 1 |
| Barreda, L; Calisto, JL; Milian, W; Pando, E; Portugal, J; Sequeiros, J; Targarona, J | 1 |
| Asner, S; Buclin, T; Calandra, T; Erard, V; Lamoth, F; Marchetti, O | 1 |
| Bragatti, JA; Cabral, L; Finkelsztejn, A; Schuh, AF; Silva, AV | 1 |
| Ii, M; Iizawa, Y; Sha, T | 1 |
| Aygencel, G; Dizbay, M | 1 |
| Basu, S; Das, P; Roy, S; Singh, AK; Viswanathan, R | 1 |
| Basu, S; Nandy, RK; Roy, S; Singh, AK; Viswanathan, R | 1 |
| Hou, J; Jiang, WL; Xu, Y; Zhang, SP; Zhu, HB | 1 |
| Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Vorob'eva, TIu | 1 |
| Jiang, WL; Zhang, SP; Zhu, HB | 1 |
| Bansal, N; Chander, J; Gupta, V; Singla, N | 1 |
| Harada, S; Ishii, Y; Kimura, S; Livermore, DM; Saga, T; Tateda, K; Woodford, N; Yamaguchi, K; Yoshizumi, A | 1 |
| Estève, E; Georgescu, V; Lespessailles, E; Martin, L; Poisson, DM | 1 |
| Cirioni, O; Ghiselli, R; Giacometti, A; Mocchegiani, F; Saba, V; Scalise, G; Viticchi, C | 1 |
| Qin, X; Xiao, G; Xu, N; Yuan, J; Zheng, J | 1 |
| Kartavenko, VI; Men'shikova, ED; Mironov, AV; Shabanov, AK; Vasina, TA | 1 |
| Amiot, DM; Buchman, TG; Coopersmith, CM; Davis, CG; Dunne, WM; Hotchkiss, RS; Husain, KD; Karl, IE; Osborne, DF; Stromberg, PE; Turnbull, IR | 1 |
| Alvarez-Lerma, F; Blanco, A; Domínguez-Muñoz, JE; Gener, J; Maraví-Poma, E; Olaechea, P | 1 |
| Balzano, A; Manes, G; Menchise, A; Rabitti, PG; Riccio, E; Uomo, G | 1 |
| Buchman, TG; Coopersmith, CM; Hotchkiss, RS; Javadi, P; Karl, IE; Turnbull, IR | 1 |
| Amâncio, RT; Bozza, FA; Bozza, PT; Castro-Faria-Neto, HC; David, CM; Gomes, RN; Vianna, RC | 1 |
| Doerschug, KC; Hunninghake, GW; Monick, MM; Powers, LS; Thorne, PS | 1 |
| Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Kamysz, W; Lukasiak, J; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C | 1 |
| Balaban, N; Cirioni, O; D'Amato, G; Del Prete, MS; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C | 1 |
| Adembri, C; De Gaudio, AR; Fallani, S; Livi, P; Mazzei, T; Novelli, A | 1 |
| Buchman, TG; Coopersmith, CM; Dipasco, PJ; Hotchkiss, RS; Javadi, P; Vyas, D | 1 |
| Cirioni, O; Ghiselli, R; Giacometti, A; Kamysz, W; Licci, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C; Łukasiak, J | 1 |
| Chaowagul, W; Fisher, CJ; Helterbrand, J; LaRosa, SP; Opal, SM; Simpson, AJ; Utterback, B; White, NJ; Yan, SC | 1 |
| Aydin, K; Aydin, S; Caylan, R; Koksal, I; Yenilmez, E; Yulug, E | 1 |
| Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M | 1 |
| Barnea, Y; Carmeli, Y; Gur, E; Hammer-Munz, O; Kuzmenko, B; Navon-Venezia, S | 1 |
| Archontoulis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Mega, A; Pavleas, I; Rigas, K; Thomopoulos, G; Vernikos, P | 1 |
| Enoh, VT; Lin, CY; Lin, SH; Murphey, ED; Sherwood, ER; Toliver-Kinsky, T; Varma, TK | 1 |
| Barauskas, G; Dambrauskas, Z; Gulbinas, A; Pundzius, J | 1 |
| Bochnia, M; Fraczek, M; Jankowska-Konsur, A; Jaworska, M; Kubacka, M; Mazur, M; Preś, K; Rostkowska-Nadolska, B; Steinmetz-Beck, A | 1 |
| Ahmed, S; Akhter, M; Begum, SA; Hasan, MK; Lutfor, AB; Mollah, AH; Salauddin, NM | 1 |
| Guevara, A; Guevara, E; Guevara, M; Medina, L; Oliveros, M; Salomón, M | 1 |
| Etoh, T; Hirose, M; Ishibashi, H; Muro, H; Ohta, S; Shirasu, T; Suzuki, K; Tanio, N | 1 |
| Kojima, T; Kusaba, T; Mashiba, K; Ootsuka, T | 1 |
| Cohn, DL; Reimer, LG; Reller, LB | 1 |
| Calia, FM; Johnson, DE; Schimpff, SC; Snyder, MJ; Warren, JW | 1 |
| Gutiérrez-Núñez, J; Harrington, PT; Ramirez-Ronda, CH | 1 |
| Ciaccia, D; Corey, GR; Peters, W; Thel, MC; Vredenburgh, JJ | 1 |
| Bucklin, SE; Morrison, DC | 1 |
| Godfroid, N; Stalens, JP | 1 |
| Giercksky, KE; Lundblad, R | 1 |
| Allen, DM; Ang, PT; Au, E; Tow, A | 1 |
| Chandy, M; Ebenezer, S; Jesudason, MV; Lalitha, MK | 1 |
| Fujita, K; Hatae, Y; Kon-No, M; Nagashima, T; Nakadate, H; Suzuki, Y; Takahashi, Y; Takase, A; Takeda, T; Wagatsuma, Y | 1 |
| Grayson, ML; Stuart, RL; Turnidge, J | 1 |
| Demirel, M; Eskitürk, A; Haklar, G; Işgör, A; Peker, O; Söyletir, G; Yalçin, AS | 1 |
| Ariga, K; Shinagawa, N; Suzuki, K; Yamakoshi, M; Yamamoto, T | 1 |
| Maezawa, H; Nakazawa, Y; Saitoh, A; Sakai, O; Sakamoto, M; Saruta, K; Shiba, K; Shindo, N; Yoshida, M; Yoshikawa, K | 1 |
| Deguchi, K; Fukayama, S; Fukumoto, T; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Tanaka, S | 1 |
| Chiritso, BG; Gal'tseva, IV; Grinev, MV; Shapot, IuB; Tsibin, IuN | 1 |
| Bille, J; Devriese, LA; Dominguez, J; Greub, G; Pot, B | 1 |
| Asano, K; Fuse, A; Hashizume, T; Nagano, R; Naito, T; Nakagawa, S; Shibata, K | 1 |
| Klastersky, J | 1 |
| Müller, P; Wertenbruch, R | 1 |
| Bolgos, G; Green, L; Newcomb, D; Remick, DG | 1 |
| Ball, S; Civetta, JM; Harvill, S; McKenney, MG; Namias, N; Salomone, JP; Sleeman, D | 1 |
| Hogaboam, CM; Kunkel, SL; Lukacs, NW; Steinhauser, ML; Strieter, RM | 1 |
| Geddes, A; Härkönen, M; Jacobs, F; Nowotny, I; Schonwald, S; Thaler, M | 1 |
| Horn, DL; Morrison, DC; Norimatsu, M; Silverstein, R; Wood, JG; Xue, Q | 1 |
| Fung, CP; Kuo, BI; Liu, CY | 1 |
| Chambers, H; Horn, D; Lemke, J; Luchi, M; Morrison, DC; Opal, S; Ryan, JL; Slotman, G; Wiesenfeld, H; Yoneda, K | 1 |
| Belágyi, T; Oláh, A; Pardavi, G | 1 |
| Brollo, L; Dal Pos, L; Furlanut, M; Lugano, M; Pea, F | 1 |
| Ağca, B; Kalyoncu, A; Mihmanli, A; Sahin, I; Sakiz, D; Tahaoğlu, K; Tuncer, F | 1 |
| Belágyi, T; Issekutz, A; Mohamed, GE; Nagy, A; Oláh, A; Pardavi, G | 1 |
| Badolati, A; Fontán, PA; Gammella, D; Maskin, B; Spinedi, EG | 1 |
| Kuroe, K; Nakaji, S; Ogasawara, H; Saito, S; Sakata, Y; Sawada, Y; Shinagawa, H; Soma, N; Takami, H; Tsushima, K | 1 |
| Biaggi, G; de'Clari, F; Magnoli, P; Menghini, T | 1 |
| Björkholm, MJ; Engervall, PA; Günther, GC; Stiernstedt, GT | 1 |
| Bom, VJ; de Vries-Hospers, HG; Dofferhoff, AS; Hazenberg, BP; Mulder, PO; van der Meer, J; van Ingen, J; Weits, J | 1 |
| Brion, JP; Croize, J; Duborgel, S; Janbon, B; Le Noc, P; Micoud, M; Recule, C | 1 |
| Asmus, S; Bodmann, KF; Hartenauer, U; Koch, EM; Ritzerfeld, WW; Weilemann, LS | 1 |
| Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP | 1 |
| Bazin, C; Deboscker, Y; Fourrier, F; Moulront, S; Mouton, Y; Philippon, A; Socolovsky, C; Suinat, JL; Tondriaux, A | 1 |
| Gamillscheg, A; Hauer, C; Lackner, H; Slavc, I; Urban, C | 1 |
| Baetz, R; Borner, K; Lebahn, K; Lode, H; Olschewski, P; Reinke, M; Sievers, H; Wagner, J; Wiley, E; Wintermantel, M | 1 |
| Giacometti, A; Petrelli, E; Pongetti, P; Scalise, G | 1 |
| Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
| Albanese, J; Brunel, MF; Durbec, O; Granthil, C; Soula, F | 1 |
| Aitchison, JM; Linton, DM; Potgieter, PD | 1 |
| Inderlied, CB; Kolonoski, PT; Wu, M; Young, LS | 1 |
| Aufrant, C; Bompard, Y; Chastel, A; Gantzer, A; Lambert, T; Voinnesson, A | 1 |
| Weinstein, MP | 1 |
| Kim, KS | 3 |
| Alvarez, ME; Bodey, GP; Elting, L; Fainstein, V; Jones, P; Rolston, K | 1 |
| Del Valle, J; Noriega, AR; Otero, JR; Revilla, AP; Sanz, F | 1 |
| Fujita, K; Inyaku, F; Kakehashi, H; Maruyama, S; Murono, K; Ohmi, H; Sakata, H; Sanae, N; Yoshioka, H | 1 |
| Horiguchi, S; Kusunoki, Y; Nagamatsu, I; Takase, A; Tateno, Y; Wagatsuma, Y | 1 |
| Alvarez, ME; Bodey, GP; Fainstein, V; Jones, P; Rolston, K; Steelhammer, L | 1 |
| Cumberland, NS; Jones, KP | 1 |
| Chadwick, EG; Shulman, ST; Yogev, R | 1 |
| Alvarez, ME; Bodey, GP; Fainstein, V; Jones, PG; Rolston, KV; Steelhammer, L | 1 |
| Aebert, H; Bunzendahl, H; Hünefeld, G; Weissbrodt, H | 1 |
| Eron, LJ | 1 |
| Starr, SE | 1 |
4 review(s) available for imipenem, anhydrous and Blood Poisoning
| Article | Year |
|---|---|
Meta-analysis of prophylactic parenteral antibiotic use in acute necrotizing pancreatitis.
Topics: Antibiotic Prophylaxis; Carbapenems; Data Interpretation, Statistical; Evidence-Based Medicine; Humans; Imipenem; Incidence; Injections, Intravenous; Necrosis; Odds Ratio; Pancreas; Pancreatitis, Acute Necrotizing; Pefloxacin; Prevalence; Randomized Controlled Trials as Topic; Risk; Risk Factors; Sepsis; Time Factors; Tomography, X-Ray Computed | 2007 |
[A case of psoas abscess associated in the elderly].
Topics: Aged; Aged, 80 and over; Cilastatin; Diabetes Complications; Drainage; Drug Therapy, Combination; Escherichia coli Infections; Humans; Imipenem; Male; Proteus Infections; Proteus mirabilis; Psoas Abscess; Sepsis | 1996 |
[Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Meropenem; Neutropenia; Sepsis; Thienamycins | 1997 |
Antimicrobial therapy of bacterial sepsis in the newborn infant.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bacteria; Cephalosporins; Cross Infection; Drug Therapy, Combination; Humans; Imipenem; Infant Mortality; Infant, Newborn; Penicillin Resistance; Penicillins; Sepsis; Thienamycins | 1985 |
27 trial(s) available for imipenem, anhydrous and Blood Poisoning
| Article | Year |
|---|---|
Comparable Effect of Two-Step Versus Extended Infusions on the Pharmacokinetics of Imipenem in Patients with Sepsis and Septic Shock.
Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis; Shock, Septic; Treatment Outcome | 2020 |
[Is the prophylactic antibiotic therapy with Imipenem effective for patients with pancreatic necrosis?].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Female; Humans; Imipenem; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sepsis; Young Adult | 2009 |
Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin.
Topics: Aged; Antibiotic Prophylaxis; APACHE; Cause of Death; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Administration Schedule; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Incidence; Infection Control; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Prospective Studies; Sepsis; Severity of Illness Index; Spain; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Pancreatitis, Acute Necrotizing; Prospective Studies; Sepsis; Thienamycins; Time Factors; Treatment Outcome | 2003 |
Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Critical Illness; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sepsis; Thienamycins | 2005 |
Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antithrombins; Biomarkers; Burkholderia pseudomallei; Ceftazidime; Cytokines; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Humans; Imipenem; Injections, Intravenous; Logistic Models; Male; Melioidosis; Middle Aged; Protein C; Protein S; Retrospective Studies; Sepsis; Thailand; Treatment Outcome | 2006 |
Management of diabetic foot in a Jordanian hospital.
Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection | 2005 |
Impact of carbapenem administration on systemic endotoxemia in patients with severe sepsis and Gram-negative bacteremia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxemia; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Sepsis | 2006 |
Randomised study comparing imipenem/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever.
Topics: Antineoplastic Agents; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Costs and Cost Analysis; Drug Combinations; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Imipenem; Male; Middle Aged; Neutropenia; Sepsis | 1994 |
[A multi-institutional study on the efficacy and toxicity of imipenem/cilastatin sodium in severe infections complicating hematological diseases and cancers in children. Study Group of Infectious Diseases in Pediatric Hematology/Oncology in Hokkaido].
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Leukemia; Leukopenia; Male; Neoplasms; Pneumonia; Sepsis | 1993 |
[A trial of the clinical use of thienam in treating severe and life-threatening suppurative-septic complications].
Topics: Acute Disease; Adult; Aged; Bacteria; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Sepsis | 1996 |
Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Middle Aged; Ofloxacin; Protease Inhibitors; Sepsis; Thienamycins | 1999 |
Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
Topics: Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Sepsis; Thienamycins | 2000 |
A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with gram-negative urosepsis. Urosepsis Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cytokines; Double-Blind Method; Endotoxins; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Sepsis; Urinary Tract Infections | 2000 |
[Early jejunal feeding in acute pancreatitis: prevention of septic complications and multiorgan failure].
Topics: Acute Disease; Adult; Enteral Nutrition; Female; Humans; Imipenem; Jejunostomy; Male; Middle Aged; Multiple Organ Failure; Pancreatitis; Parenteral Nutrition; Prospective Studies; Sepsis; Severity of Illness Index; Survival Analysis; Thienamycins; Time Factors; Treatment Outcome | 2000 |
Early nasojejunal feeding in acute pancreatitis is associated with a lower complication rate.
Topics: Acute Disease; Adult; Enteral Nutrition; Female; Humans; Imipenem; Jejunostomy; Male; Middle Aged; Multiple Organ Failure; Pancreatitis; Parenteral Nutrition; Prospective Studies; Sepsis; Severity of Illness Index; Thienamycins | 2002 |
Evaluation of endotoxin release and cytokine production induced by antibiotics in patients with Gram-negative nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cross Infection; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Statistics, Nonparametric; Thienamycins; Tumor Necrosis Factor-alpha | 2002 |
[A randomized controlled study on imipenem/cilastatin sodium in comparison to aztreonam + lincomycin in treating severe infections in patients with malignant tumors or hematological diseases].
Topics: Adolescent; Adult; Aged; Aztreonam; Cilastatin; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Lincomycin; Male; Middle Aged; Neoplasms; Opportunistic Infections; Pneumonia; Sepsis; Urinary Tract Infections | 1992 |
Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Pneumocystis Infections; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.
Topics: Ceftazidime; Cilastatin; Cross Infection; Drug Combinations; Female; Germany, West; Humans; Imipenem; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia; Randomized Controlled Trials as Topic; Respiration, Artificial; Sepsis | 1990 |
[Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Sepsis | 1990 |
Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Ofloxacin; Pneumonia; Prospective Studies; Remission Induction; Respiratory Tract Infections; Sepsis; Ticarcillin | 1990 |
Imipenem/cilastatin treatment of acute infections in AIDS/ARC patients.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; AIDS-Related Complex; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Respiratory Tract Infections; Risk Factors; Sepsis | 1990 |
Evaluation of the efficacy and tolerance of intravenously administered imipenem/cilastatin in the treatment of septicaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Evaluation; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Multicenter Studies as Topic; Sepsis | 1989 |
Imipenem/cilastatin therapy of infections in cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Leukemia; Male; Middle Aged; Neoplasms; Pneumonia; Sepsis; Thienamycins | 1987 |
Efficacy and safety of imipenem/cilastatin in the empirical treatment of septicemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis; Thienamycins | 1987 |
Imipenem-cilastatin as initial therapy for febrile cancer patients.
Topics: Adult; Bacterial Infections; Cilastatin; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia; Sepsis; Thienamycins | 1986 |
111 other study(ies) available for imipenem, anhydrous and Blood Poisoning
| Article | Year |
|---|---|
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Colistin; DNA-Binding Proteins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides, Cyclic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Treatment Outcome | 2007 |
Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.
Topics: Amino Acid Sequence; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Capnocytophaga; Cephalosporins; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis | 2010 |
Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Disease Models, Animal; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Sepsis | 2011 |
Evaluating the usefulness of the estimated glomerular filtration rate for determination of imipenem dosage in critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albumins; Anti-Bacterial Agents; Cilastatin, Imipenem Drug Combination; Creatinine; Critical Illness; Female; Glomerular Filtration Rate; Humans; Imipenem; Male; Middle Aged; Renal Insufficiency, Chronic; Sepsis; South Africa; Young Adult | 2022 |
Examination of antimicrobial effect of fluoxetine in experimental sepsis model: An in vivo study.
Topics: Animals; Anti-Infective Agents; Antioxidants; C-Reactive Protein; Disease Models, Animal; Fluoxetine; Imipenem; Interleukin-6; Lactates; Oxidative Stress; Rats; Sepsis; Tumor Necrosis Factor-alpha | 2023 |
Cefepime, not Piperacillin/Tazobactam use, for empirical treatment of bloodstream infections caused by Enterobacter spp.: Results from a population pharmacokinetic/pharmacodynamic analysis.
Topics: Anti-Bacterial Agents; Cefepime; Enterobacter; Humans; Imipenem; Microbial Sensitivity Tests; Monte Carlo Method; Piperacillin, Tazobactam Drug Combination; Sepsis | 2023 |
A 12-Year Retrospective Analysis of Blood Culture Isolates in the Intensive Care Unit of a Tertiary Hospital in China.
Topics: Amikacin; Anti-Bacterial Agents; Blood Culture; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Intensive Care Units; Linezolid; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Sepsis; Teicoplanin; Tertiary Care Centers; Vancomycin | 2023 |
[Application of Rapid Detection Method Based on NG-Test® CARBA 5 in Bloodstream Infections Associated With Carbapenem-Resistant Enterobacterales].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis | 2023 |
The combination of mesenchymal stem cell- and hepatocyte-derived exosomes, along with imipenem, ameliorates inflammatory responses and liver damage in a sepsis mouse model.
Topics: Animals; Cytokines; Exosomes; Hepatocytes; Imipenem; Inflammation; Liver; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Sepsis | 2023 |
Inhibition of Dimethylarginine Dimethylaminohydrolase 1 Improves the Outcome of Sepsis in Pregnant Mice.
Topics: Amidohydrolases; Animals; Arginine; Cytokines; Female; Flow Cytometry; Imipenem; Male; Mice; Sepsis | 2020 |
Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Toxins; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Drug Resistance, Bacterial; Feces; Female; Humans; Imipenem; Kuwait; Male; Meropenem; Metronidazole; Microbial Sensitivity Tests; Piperacillin; Prevalence; Prospective Studies; Respiratory Tract Infections; Sepsis; Tigecycline; Wound Infection | 2020 |
Association Between Pathophysiology and Volume of Distribution Among Patients With Sepsis or Septic Shock Treated With Imipenem: A Prospective Cohort Study.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Imipenem; Linear Models; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Sepsis; Shock, Septic | 2020 |
Imipenem alters systemic and liver inflammatory responses in CLP- induced sepsis mice in a dose-dependent manner.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cecum; Cytokines; Disease Models, Animal; Endotoxins; Female; Humans; Imipenem; Injections, Subcutaneous; Liver; Mice; Mice, Inbred C57BL; Sepsis | 2021 |
Intestinal microbiota and antibiotic-associated acute gastrointestinal injury in sepsis mice.
Topics: Animals; Anti-Bacterial Agents; Cilastatin; Feces; Gastrointestinal Microbiome; Gastrointestinal Motility; Imipenem; Male; Mice; RNA, Ribosomal, 16S; Sepsis | 2021 |
Activity of imipenem/relebactam and comparators against gram-negative pathogens from patients with bloodstream infections in the United States and Canada - SMART 2018-2019.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Canada; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sepsis; United States | 2021 |
Postpartum septic pelvic thrombophlebitis and ovarian vein thrombosis after caesarean section: a rare case report.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Cesarean Section; Female; Heparin; Humans; Imipenem; Ovary; Pregnancy; Sepsis; Thrombophlebitis; Veins; Venous Thrombosis | 2021 |
Why Antibiotic Treatment Is Not Enough for Sepsis Resolution: an Evaluation in an Experimental Animal Model.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Imipenem; Mice; Sepsis; Survival Analysis; Treatment Outcome | 2017 |
[Protective effects of recombinant trichinella spiralis-53 000 protein combining with imipenem on polymicrobial septic mice].
Topics: Animals; Cytokines; Imipenem; Interleukin-10; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Recombinant Proteins; Sepsis; Trichinella spiralis; Tumor Necrosis Factor-alpha | 2016 |
Imipenem and normal saline with cyclophosphamide have positive effects on the intestinal barrier in rats with sepsis.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Cyclophosphamide; Cytokines; Drug Combinations; Imipenem; Immunosuppressive Agents; Intestinal Mucosa; Male; Occludin; Permeability; Rats, Sprague-Dawley; Sepsis; Sodium Chloride | 2018 |
Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Colistin; Critical Illness; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Prospective Studies; Sepsis | 2018 |
Clinical Situations of Bacteriology and Prognosis in Patients with Urosepsis.
Topics: Ertapenem; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella pneumoniae; Quinolones; Sepsis; Shock, Septic; Urinary Tract Infections | 2019 |
Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactamases; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Female; Imipenem; Injections, Intramuscular; Injections, Intraperitoneal; Intraabdominal Infections; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Treatment Outcome | 2013 |
Impact of imipenem treatment on colonic mycobiota in rats with double-hit sepsis.
Topics: Animals; Anti-Bacterial Agents; Burns; Candida; Colon; Imipenem; Male; Rats; Rats, Sprague-Dawley; Sepsis; Trichosporon | 2013 |
The first case of septicemia caused by imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae.
Topics: Aged; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Phenotype; Sepsis; Thienamycins | 2013 |
Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Sepsis; Sulbactam; Tigecycline; Time Factors | 2013 |
Epinecidin-1 has immunomodulatory effects, facilitating its therapeutic use in a mouse model of Pseudomonas aeruginosa sepsis.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Behavior, Animal; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Fish Proteins; Humans; Imipenem; Immunologic Factors; Male; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Survival Analysis; Toxicity Tests, Acute | 2014 |
Low-dose cyclophosphamide improves survival in a murine treatment model of sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Cyclophosphamide; Disease Models, Animal; Imipenem; Immunosuppressive Agents; Lung; Macrophages, Peritoneal; Male; Mice; Mice, Inbred ICR; Peyer's Patches; Phagocytosis; Sepsis | 2015 |
A Non-inferiority Pilot Study Comparing the Clinical Efficacy and Safety of Generic Wide-spectrum Antibiotic Use in Septic Oncology Patients.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drugs, Generic; Female; Humans; Imipenem; Male; Middle Aged; Oncology Service, Hospital; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Sepsis; Sulbactam; Treatment Outcome | 2015 |
Combined treatment with atorvastatin and imipenem improves survival and vascular functions in mouse model of sepsis.
Topics: Animals; Anti-Bacterial Agents; Atorvastatin; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipenem; Male; Mice; Organ Culture Techniques; Sepsis; Survival Rate | 2015 |
Anti-inflammatory and anti-bacterial effects of iron chelation in experimental sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Capillaries; Cell Adhesion; Drug Therapy, Combination; Imipenem; Injections, Intraperitoneal; Iron Chelating Agents; Leukocytes; Male; Mice; Mice, Inbred C57BL; Sepsis | 2016 |
Successful Treatment of Chromobacterium violaceum Sepsis in a South Indian Adult.
Topics: Abscess; Anti-Bacterial Agents; Chromobacterium; Ciprofloxacin; Female; Humans; Imipenem; India; Melioidosis; Middle Aged; Sepsis; Treatment Outcome | 2015 |
Atorvastatin along with imipenem attenuates acute lung injury in sepsis through decrease in inflammatory mediators and bacterial load.
Topics: Acute Lung Injury; Animals; Atorvastatin; Bacterial Load; Drug Therapy, Combination; Imipenem; Inflammation Mediators; Male; Mice; Sepsis | 2015 |
Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Colistin; Enzyme-Linked Immunosorbent Assay; Imipenem; Interleukin-10; Lysophosphatidylcholines; Mice; Microbial Sensitivity Tests; Minocycline; Pneumonia; Sepsis; Tigecycline; Tumor Necrosis Factor-alpha | 2016 |
[Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacteriophages; Burns; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Liver; Mice; Mice, Inbred BALB C; Random Allocation; Sepsis; Soft Tissue Infections; Stem Cells | 2016 |
Late Therapeutic Intervention with Antibiotics and Fluid Resuscitation Allows for a Prolonged Disease Course with High Survival in a Severe Murine Model of Sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cytokines; Disease Models, Animal; Fluid Therapy; Imipenem; Male; Mice; Mice, Inbred C57BL; Sepsis | 2017 |
Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis.
Topics: Animals; Anti-Bacterial Agents; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Cecum; Cilastatin; Cilastatin, Imipenem Drug Combination; Cytokines; Dependovirus; Disease Models, Animal; Drug Combinations; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Ligation; Male; Mice; Mice, Inbred C57BL; Receptors, Scavenger; Sepsis | 2017 |
Serious postpartum infection due to MRSA in an asymptomatic carrier: case report and review.
Topics: Abscess; Anti-Bacterial Agents; Anticoagulants; Carrier State; Cesarean Section; Cilastatin; Cilastatin, Imipenem Drug Combination; Drainage; Drug Combinations; Female; Heparin; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Pregnancy; Puerperal Infection; Pulmonary Embolism; Radiography; Sepsis; Staphylococcal Infections; Surgical Wound Infection; Thrombophlebitis; Vancomycin; Young Adult | 2008 |
Effect of cornuside on experimental sepsis.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Cornus; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Therapy, Combination; Endotoxins; Fruit; Glucosides; Imipenem; Immunologic Factors; Inflammation Mediators; Macrophages; Male; Myeloid Cells; Nitric Oxide; Peroxidase; Phytotherapy; Plant Extracts; Pyrans; Random Allocation; Rats; Rats, Sprague-Dawley; Sepsis; Up-Regulation | 2009 |
Rosmarinic acid protects against experimental sepsis by inhibiting proinflammatory factor release and ameliorating hemodynamics.
Topics: Animals; Anti-Bacterial Agents; Cinnamates; Depsides; Disease Models, Animal; Endotoxins; Gene Expression Regulation; Hemodynamics; Humans; Imipenem; Inflammation; Male; Mice; Myeloid Cells; Rats; Rats, Sprague-Dawley; Rosmarinic Acid; Sepsis; Tretinoin | 2009 |
High imipenem blood concentrations associated with toxic encephalopathy in a patient with mild renal dysfunction.
Topics: Aged; Anti-Bacterial Agents; Catheter-Related Infections; Enterocolitis; Fatal Outcome; Female; Humans; Imipenem; Kidney Diseases; Neurotoxicity Syndromes; Sepsis; Staphylococcal Infections; Staphylococcus haemolyticus; Vancomycin | 2009 |
Imipenem-associated encephalopathy: alert to physicians.
Topics: Aged; Anti-Bacterial Agents; Brain Diseases; Humans; Imipenem; Klebsiella Infections; Male; Sepsis | 2010 |
Combination of imipenem and TAK-242, a Toll-like receptor 4 signal transduction inhibitor, improves survival in a murine model of polymicrobial sepsis.
Topics: Animals; Anti-Bacterial Agents; Cytokines; Dose-Response Relationship, Drug; Female; Imipenem; Mice; Mice, Inbred ICR; Sepsis; Signal Transduction; Sulfonamides; Time Factors; Toll-Like Receptor 4 | 2011 |
Severe systemic sepsis due to pyogenic liver abscess.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fatal Outcome; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess, Pyogenic; Male; Middle Aged; Sepsis | 2012 |
Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Humans; Imipenem; India; Infant, Newborn; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis | 2011 |
Transmission of imipenem resistance determinants during the course of an outbreak of NDM-1 Escherichia coli in a sick newborn care unit.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Disease Outbreaks; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Humans; Imipenem; Infant, Newborn; Male; Molecular Sequence Data; Sepsis; Sequence Analysis, DNA | 2011 |
Protocatechuic aldehyde protects against experimental sepsis in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Benzaldehydes; Catechols; Cell Line; Disease Models, Animal; Drug Therapy, Combination; HMGB1 Protein; Imipenem; Inflammation; Inflammation Mediators; Injections, Intravenous; Interleukin-10; Macrophages; Male; NF-kappa B; Phosphorylation; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2012 |
[Antibiotic susceptibility of isolates from blood of patients in intensive care units of emergency medical service].
Topics: Acetamides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Candida; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infection Control; Intensive Care Units; Linezolid; Meropenem; Moscow; Oxazolidinones; Sepsis; Thienamycins; Vancomycin | 2011 |
Forsythoside B protects against experimental sepsis by modulating inflammatory factors.
Topics: Animals; Caffeic Acids; Cell Line; Glucosides; HMGB1 Protein; I-kappa B Kinase; Imipenem; Inflammation Mediators; Interleukin-10; Interleukin-6; Intestine, Small; Lipopolysaccharides; Liver; Lung; Male; Mice; NF-kappa B; Peroxidase; Rats; Rats, Sprague-Dawley; Receptors, Immunologic; Sepsis; Triggering Receptor Expressed on Myeloid Cells-1; Tumor Necrosis Factor-alpha | 2012 |
Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Prevalence; Sepsis; Tertiary Care Centers; Thienamycins | 2013 |
Efficacies of calcium-EDTA in combination with imipenem in a murine model of sepsis caused by Escherichia coli with NDM-1 β-lactamase.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactam Resistance; beta-Lactamases; Colony Count, Microbial; Disease Models, Animal; Edetic Acid; Escherichia coli; Escherichia coli Infections; Imipenem; Mice; Microbial Sensitivity Tests; Sepsis | 2013 |
[Digital purpura revealing septicaemical rat-bite fever].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Infectious; Diagnosis, Differential; Female; Fingers; Humans; Imipenem; Ofloxacin; Purpura; Rat-Bite Fever; Sepsis; Streptobacillus; Treatment Outcome | 2002 |
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Colistin; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Endotoxins; Exudates and Transudates; Imipenem; Male; Peritonitis; Proteins; Rats; Rats, Wistar; Sepsis; Tumor Necrosis Factor-alpha | 2002 |
[An experimental study of the LPS release from gram-negative bacteria induced by antibiotics (Part two)].
Topics: Animals; Anti-Bacterial Agents; Burns; Ceftazidime; Cell Division; Colony Count, Microbial; Female; Galactosamine; Imipenem; Lipopolysaccharides; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Sepsis; Survival Rate; Time Factors | 2002 |
[Antibacterial activity of imipenem/cilastatin (thienam) against agents causing pyoseptic processes].
Topics: Bacteria; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Sepsis; Suppuration | 2002 |
Antibiotics improve survival and alter the inflammatory profile in a murine model of sepsis from Pseudomonas aeruginosa pneumonia.
Topics: Animals; Anti-Bacterial Agents; Biomarkers; Cytokines; Disease Models, Animal; Gentamicins; Imipenem; Interleukin-6; Lipopolysaccharides; Mice; Mice, Inbred Strains; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Survival Analysis; Time Factors | 2003 |
Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with markedly elevated interleukin 6 levels.
Topics: Animals; Anti-Bacterial Agents; Cecum; Imipenem; Interleukin-6; Male; Mice; Sepsis; Sodium Chloride; Time Factors | 2004 |
Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cecum; Ciprofloxacin; Clindamycin; Colony-Forming Units Assay; Cytokines; Disease Models, Animal; Endotoxins; Enzyme-Linked Immunosorbent Assay; Female; Gram-Negative Bacteria; Imipenem; Inflammation; Interleukin-10; Interleukin-6; Leukocytes; Lipopolysaccharides; Male; Mice; Sepsis; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
Antibiotics delay but do not prevent bacteremia and lung injury in murine sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Female; Imipenem; Mice; Mice, Inbred C57BL; Prospective Studies; Random Allocation; Respiratory Distress Syndrome; Sepsis; Time Factors | 2004 |
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.
Topics: Abdominal Cavity; Animals; Antimicrobial Cationic Peptides; Disease Models, Animal; Endotoxins; Histatins; Imipenem; Male; Microbial Sensitivity Tests; Plasma; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Salivary Proteins and Peptides; Sepsis; Survival Analysis; Tumor Necrosis Factor-alpha | 2004 |
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cefazolin; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Imipenem; Male; Mice; Mice, Inbred BALB C; Oligopeptides; Random Allocation; Sensitivity and Specificity; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 2005 |
Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels.
Topics: Animals; Anti-Bacterial Agents; Antibodies; Imipenem; Interleukin-6; Male; Mice; Sepsis; Survival Analysis; Survival Rate; Treatment Outcome | 2005 |
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Imipenem; Male; Mice; Mice, Inbred BALB C; Proteins; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2005 |
The influence of G-CSF addition to antibiotic treatment of experimental sepsis on pulmonary tissue.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Imipenem; Leukocyte Count; Lung Diseases; Neutrophils; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Sepsis; Survival Analysis; Treatment Outcome | 2005 |
The establishment of a Pseudomonas aeruginosa-infected burn-wound sepsis model and the effect of imipenem treatment.
Topics: Animals; Anti-Bacterial Agents; Burns; Female; Imipenem; Mice; Mice, Inbred C57BL; Pseudomonas Infections; Sepsis; Treatment Outcome; Wound Healing | 2006 |
Mice depleted of alphabeta but not gammadelta T cells are resistant to mortality caused by cecal ligation and puncture.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacteria; Cecum; Chemokine CXCL2; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Imipenem; Interleukin-6; Killer Cells, Natural; Ligation; Mice; Mice, Inbred C57BL; Mice, Knockout; Monokines; Punctures; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Sepsis; T-Lymphocytes; Temperature; Time Factors | 2007 |
[Sepsis in the sphenoiditis patient].
Topics: Abscess; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Middle Aged; Radiography; Sepsis; Sphenoid Sinus; Sphenoid Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2007 |
Salmonella-a new threat to neonates.
Topics: Bangladesh; Ciprofloxacin; Cross-Sectional Studies; Female; Humans; Imipenem; Infant, Newborn; Male; Salmonella Infections; Salmonella paratyphi A; Salmonella paratyphi B; Salmonella typhi; Sepsis; Systemic Inflammatory Response Syndrome | 2007 |
[Sepsis caused by pigmented and no pigmented Chromobacterium violaceum].
Topics: Amikacin; Anti-Bacterial Agents; Chromobacterium; Fatal Outcome; Gram-Negative Bacterial Infections; Humans; Imipenem; Indians, South American; Infant; Male; Psoas Abscess; Sepsis | 2007 |
[Postoperative penicillin-resistant streptococcus pneumonia in lung cancer patient].
Topics: Aged; Carcinoma, Squamous Cell; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Fatal Outcome; Humans; Imipenem; Klebsiella Infections; Lung Neoplasms; Male; Penicillin Resistance; Pneumonia, Pneumococcal; Postoperative Complications; Sepsis; Streptococcus pneumoniae; Ventilators, Mechanical | 2008 |
[Yersinia psuedotuberculosis septicemia in a healthy young woman].
Topics: Adult; Anti-Bacterial Agents; Antibodies, Bacterial; Biomarkers; Female; Humans; Imipenem; Sepsis; Serologic Tests; Tretoquinol; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections | 2008 |
Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates.
Topics: Anti-Bacterial Agents; Bacteria; Cephalothin; Cephamycins; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Sepsis; Tobramycin | 1982 |
Imipenem therapy of Pseudomonas aeruginosa bacteraemia in neutropenic rats.
Topics: Agranulocytosis; Animals; Drug Synergism; Female; Imipenem; Lethal Dose 50; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis; Thienamycins | 1983 |
Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Cross Infection; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Sepsis | 1982 |
Clostridium septicum abscess in hepatic metastases: successful medical management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carmustine; Ceftazidime; Cisplatin; Clindamycin; Clostridium Infections; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Gases; Granulocyte Colony-Stimulating Factor; Humans; Imipenem; Immunocompromised Host; Liver Abscess; Liver Neoplasms; Methotrexate; Neutropenia; Sepsis | 1994 |
Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Ceftazidime; Cell Wall; Escherichia coli Infections; Female; Galactosamine; Gram-Negative Bacterial Infections; Imipenem; Lipopolysaccharides; Mice; Mice, Inbred C3H; Sepsis | 1995 |
Thigh pain due to obturator internus phlegmon: a diagnostic challenge.
Topics: Abscess; Cellulitis; Child; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Imipenem; Male; Muscle, Skeletal; Pain; Sepsis; Staphylococcal Infections; Thigh; Tomography, X-Ray Computed | 1995 |
Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intra-abdominal sepsis in rats.
Topics: Animals; Antibodies, Monoclonal; Blood Volume; Cilastatin; Cilastatin, Imipenem Drug Combination; Combined Modality Therapy; Drug Combinations; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endothelins; Fluid Therapy; Imipenem; Immunoglobulins; Male; Peritonitis; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Sepsis; Time Factors | 1995 |
In vitro evaluation of newer beta-lactam antibiotics against gram negative bacilli isolated from neutropenic patients.
Topics: Anti-Bacterial Agents; Azlocillin; Clavulanic Acid; Clavulanic Acids; Drug Evaluation; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Neutropenia; Piperacillin; Pseudomonas aeruginosa; Sepsis; Ticarcillin | 1994 |
Safety of imipenem in neonates.
Topics: Dose-Response Relationship, Drug; Humans; Imipenem; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Sepsis; Thienamycins; Treatment Outcome | 1995 |
The effects of experimental splenic autotransplantation and imipenem-cilastatin treatment in postsplenectomy Pseudomonas aeruginosa sepsis.
Topics: Animals; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Hemoglobins; Imipenem; Immunoglobulin M; Lung; Male; Oxygen; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Sepsis; Spleen; Splenectomy; Transplantation, Autologous | 1995 |
[Two cases of gram-positive sepsis successfully treated with vancomycin in combination with imipenem or cilastatin].
Topics: Adolescent; Cilastatin; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Sepsis; Vancomycin | 1996 |
[Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
Topics: Ampicillin; Blood; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Escherichia coli; Humans; Imipenem; Listeria monocytogenes; Meningitis, Bacterial; Meropenem; Penicillins; Sepsis; Streptococcus agalactiae; Streptococcus pneumoniae; Thienamycins | 1996 |
Enterococcus cecorum septicemia in a malnourished adult patient.
Topics: Adult; Bacterial Typing Techniques; Blood; Diagnosis, Differential; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Imipenem; Nutrition Disorders; RNA, Ribosomal, 16S; Sepsis; Species Specificity; Thienamycins | 1997 |
Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Dipeptidases; Imipenem; Kidney; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muscle, Skeletal; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
[Right-heart endocarditis after pacemaker implantation as a cause of a round pulmonary infiltrate].
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Follow-Up Studies; Gentamicins; Humans; Imipenem; Male; Middle Aged; Pacemaker, Artificial; Radiography, Thoracic; Sepsis; Staphylococcal Infections; Teicoplanin; Thienamycins; Time Factors | 1998 |
Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity.
Topics: Animals; Anti-Bacterial Agents; Body Temperature; Cecum; Ciprofloxacin; Clindamycin; Cytokines; Drug Therapy, Combination; Gentamicins; Imipenem; Interleukin-1; Interleukin-6; Lung; Mice; Mice, Inbred BALB C; Morbidity; Neutrophils; Peroxidase; Sepsis; Survival Rate; Tumor Necrosis Factor-alpha | 1998 |
Empiric therapy of sepsis in the surgical intensive care unit with broad-spectrum antibiotics for 72 hours does not lead to the emergence of resistant bacteria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Care; Drug Resistance, Microbial; Drug Therapy, Combination; Empiricism; Female; Gentamicins; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis; Thienamycins; Time Factors | 1998 |
Multiple roles for IL-12 in a model of acute septic peritonitis.
Topics: Acute Disease; Animals; Cecal Diseases; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Female; Fibrosis; Imipenem; Immune Sera; Immunization, Passive; Interferon-gamma; Interleukin-10; Interleukin-12; Intestinal Perforation; Ligation; Mice; Peritoneum; Peritonitis; Sepsis; Wound Healing | 1999 |
Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ceftazidime; Cell Adhesion; Cell Movement; Cephalosporins; Dexamethasone; Endothelium, Vascular; Escherichia coli; Female; Galactosamine; Imipenem; Kinetics; Leukocytes; Male; Mice; Microcirculation; Rats; Rats, Sprague-Dawley; Sepsis; Staphylococcus aureus; Thienamycins; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration.
Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Hemofiltration; Humans; Imipenem; Kidney Transplantation; Male; Multiple Organ Failure; Sepsis; Serum Albumin; Teicoplanin | 2001 |
[The effect of antibiotic therapy on lung pathology in experimental models of sepsis].
Topics: Animals; Bacteroides fragilis; Disease Models, Animal; Escherichia coli; Gram-Negative Bacterial Infections; Imipenem; Lung Diseases; Prognosis; Rats; Rats, Wistar; Sepsis; Thienamycins | 2002 |
Septicaemia due to a new species of Rhodococcus that contaminated closed system packed red blood cells--cure with imipenem monotherapy.
Topics: Actinomycetales Infections; Blood Component Transfusion; Erythrocytes; Humans; Imipenem; Rhodococcus; Sepsis | 1992 |
Patterns of cytokines, plasma endotoxin, and acute phase proteins during the treatment of severe sepsis in humans.
Topics: Acute-Phase Proteins; Cefuroxime; Cilastatin; Drug Therapy, Combination; Endotoxins; Female; Humans; Imipenem; Interleukin-1; Interleukin-6; Male; Middle Aged; Sepsis; Tobramycin; Tumor Necrosis Factor-alpha | 1991 |
[Diagnosis of Nocardia asteroides septicemia and value of imipenem in its treatment].
Topics: Adult; Humans; Imipenem; Male; Nocardia asteroides; Nocardia Infections; Sepsis | 1991 |
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin | 1990 |
Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Piperacillin; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin | 1990 |
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.
Topics: Abscess; Animals; Bacterial Infections; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Granuloma; Imipenem; Male; Mice; Mice, Hairless; Mice, Inbred C3H; Pneumonia; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections | 1990 |
[Fulminating Pseudomonas maltophilia septicemia during treatment with imipenem and amikacin].
Topics: Amikacin; Drug Resistance, Microbial; Humans; Imipenem; Male; Middle Aged; Pseudomonas; Pseudomonas Infections; Sepsis | 1989 |
Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Female; Imipenem; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Organ Size; Sepsis | 1989 |
[Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; Cilastatin; Cyclopropanes; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Sepsis; Thienamycins | 1988 |
Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Enoxacin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Sepsis; Tobramycin | 1988 |
In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes.
Topics: Ampicillin; Animals; Animals, Newborn; Cilastatin; Cyclopropanes; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Listeria monocytogenes; Listeriosis; Liver; Meningitis, Listeria; Rats; Sepsis; Spleen; Thienamycins | 1986 |
[Clinical and pharmacokinetic evaluation of imipenem/cilastatin sodium in children].
Topics: Bacterial Infections; Child; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Humans; Imipenem; Infant; Infusions, Intravenous; Kinetics; Pneumonia; Sepsis; Thienamycins; Thyroiditis; Urinary Tract Infections | 1986 |
[Clinical evaluation of imipenem/cilastatin sodium in children].
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Empyema; Female; Humans; Imipenem; Infant; Infusions, Intravenous; Kinetics; Male; Pneumonia, Staphylococcal; Pyelitis; Sepsis; Thienamycins; Tonsillitis | 1986 |
Imipenem/cilastatin as secondary therapy for infections in cancer patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cilastatin; Cyclopropanes; Dipeptidases; Female; Humans; Imipenem; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutrophils; Pneumonia; Sepsis; Thienamycins | 1986 |
Hospital acquired native valve endocarditis caused by Acinetobacter calcoaceticus and treated with imipenem/cilastin.
Topics: Acinetobacter Infections; Adult; Aortic Valve; Burns; Cilastatin; Cross Infection; Cyclopropanes; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Imipenem; Male; Military Personnel; Sepsis; Thienamycins; Wound Infection | 1987 |
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
Topics: Agranulocytosis; Amikacin; Animals; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Imipenem; Kanamycin; Kinetics; Klebsiella Infections; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Rats; Sepsis; Serratia marcescens; Thienamycins | 1986 |
[Calculated initial chemotherapy in mechanically-ventilated postoperative patients with peritonitis, sepsis and pneumonia].
Topics: Adult; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Peritonitis; Pneumonia; Postoperative Complications; Respiration, Artificial; Retrospective Studies; Sepsis; Thienamycins | 1986 |
Imipenem/cilastatin therapy of bacteremia.
Topics: Adolescent; Adult; Aged; Bacteria; Cilastatin; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Sepsis; Thienamycins | 1985 |
Efficacy of imipenem in experimental group B streptococcal bacteremia and meningitis.
Topics: Animals; Animals, Newborn; Imipenem; Meningitis; Microbial Sensitivity Tests; Rats; Sepsis; Streptococcal Infections; Streptococcus agalactiae; Thienamycins | 1985 |
Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
Topics: Ampicillin; Animals; Animals, Newborn; Cefotaxime; Chloramphenicol; Cilastatin; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Imipenem; Meningitis; Rats; Sepsis; Thienamycins | 1985 |